Advertisement
Screener

VYOME HOLDINGS, INC. (HIND) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

VYOME HOLDINGS, INC. Cash Flow Breakdown

Cash flow breakdown shows where VYOME HOLDINGS, INC.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $3.75M went out.
  • Fiscal year ended 2025-12-31: from financing, $8.65M came in.
  • Fiscal year ended 2025-12-31: change in cash, $4.88M came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingDebt paid backNew debtNew shares soldNot split outChange in cash
2025-12-31-$3.75M$600.00K$1.28M$6.77M*$4.88M
2024-12-31-$614.14K$315.00$697.95K*$85.26K
2023-12-31-$16.96M-$10.00K$13.44M$4.14M*$604.00K
2022-12-31-$21.90M-$92.00K$639.00K$2.49M*-$18.86M
2021-12-31-$15.38M$1.85M-$10.50M$417.00K$43.38M*$19.81M
2020-12-31-$8.55M-$2.39M$955.00K$10.12M*$22.00K
2019-12-31-$22.87M$2.36M-$20.00M$10.00M$23.38M-$7.13M
2018-12-31-$29.43M$19.52M$0.00$0.00$9.82M$79.00K
2017-12-31-$30.62M-$21.86M$0.00$0.00$613.00K*-$51.87M
2016-12-31-$19.37M$6.20M$0.00$0.00$1.07M$81.72M*$69.62M
2015-12-31-$11.39M$2.78M$0.00$5.00M$62.00K-$3.55M
2014-12-31-$9.91M-$7.92M-$3.00M$4.96M$8.00K$20.22M*$4.38M

Each quarter (3 month)

Quarter endRunning the businessFrom investingDebt paid backNew debtNew shares soldNot split outChange in cash
2026-06-30-$903.71K*-$3.00K*
2026-03-31-$1.44M$5.29M$3.81M
2025-12-31-$1.48M*$0.00*$603.02K*
2025-09-30-$1.76M*$0.00*-$10.18M*$17.28M*
2025-06-30-$306.25K*$6.10M*-$5.47M*
2025-03-31-$203.53K-$43.53K
2024-12-31-$2.97K*$1.47K*
2024-09-30-$374.12K*$274.00*
2024-06-30$1.83M*
2024-03-31-$2.07M-$2.08M
2023-12-31-$2.46M*$0.00*$987.00K*$4.47M*
2023-09-30-$2.78M*$0.00*$0.00*
2023-06-30-$6.66M*-$3.00K*$2.25M*
2023-03-31-$5.06M-$7.00K$10.20M$5.13M
2022-12-31-$2.83M*-$79.00K*$638.00K*
2022-09-30-$5.27M*-$33.00K*
2022-06-30-$6.42M*$18.00K*
2022-03-31-$7.38M$2.00K-$7.36M
2021-12-31-$3.43M*-$3.07M*$0.00*$0.00*
2021-09-30-$7.80M*-$89.00K*$0.00*$201.00K*-$3.23M*
2021-06-30-$2.19M*$5.13M*$35.33M*
2021-03-31-$1.96M-$119.00K$1.00M*-$1.06M
2020-12-31-$1.76M*-$2.16M*$0.00*$0.00*$0.00*$5.07M*
2020-09-30-$976.00K*-$148.00K*$0.00*$0.00*$0.00*$1.50M*
2020-06-30-$998.00K*$244.00K*$430.00K*$0.00*$4.08M*
2020-03-31-$4.81M-$326.00K$0.00$0.00-$5.14M
2019-12-31-$4.88M*-$150.00K*$0.00*$0.00*$14.72M*
2019-09-30-$3.99M*-$24.00K*-$5.00M*$0.00*-$134.00K*$15.01M*
2019-06-30-$4.36M*-$1.00K*$0.00*$8.19M*-$15.00M*
2019-03-31-$9.64M$2.53M$10.00M$607.00K$3.50M
2018-12-31-$5.42M*$5.18M*$0.00*$0.00*-$150.00K*-$365.00K*
2018-09-30-$5.29M*-$7.32M*$0.00*$0.00*$9.97M*-$2.66M*
2018-06-30-$8.12M*-$1.29M*$0.00*$0.00*-$9.27M*
2018-03-31-$10.60M$22.94M$0.00$0.00$12.37M
2017-12-31-$9.20M*$17.86M*$0.00*$9.03M*
2017-09-30-$7.02M*$13.27M*$9.00K*$6.26M*
2017-06-30-$6.05M*-$30.08M*$37.00K*-$35.88M*
2017-03-31-$8.35M-$22.91M$0.00-$31.26M
2016-12-31-$5.78M*$9.21M*$1.00K*$67.22M*$70.65M*
2016-09-30-$4.93M*$1.89M*$1.05M*-$2.00M*
2016-06-30-$3.68M*-$8.64M*$9.00K*$14.52M*$2.21M*
2016-03-31-$4.98M$3.75M$2.00K-$1.23M
2015-12-31$1.69M*

Similar stocks

Stock NameCountryMarket CapPE Ratio
Tvardi Therapeutics, Inc. (TVRD)United States$0.014B
BullFrog AI Holdings, Inc. (BFRG)United States$0.014B
ACTUATE THERAPEUTICS, INC. (ACTU)United States$0.015B
Anebulo Pharmaceuticals, Inc. (ANEB)United States$0.015B
LISATA THERAPEUTICS, INC. (LSTA)United States$0.014B-2.13
Lantern Pharma Inc. (LTRN)United States$0.015B-2.87
Vistagen Therapeutics, Inc. (VTGN)United States$0.013B-0.14
MUSTANG BIO, INC. (MBIO)United States$0.013B
Citius Pharmaceuticals, Inc. (CTXR)United States$0.016B-133.06
AEON Biopharma, Inc. (AEON)United States$0.013B-0.36